← Eichor
Condition: Malignant Pleural Mesothelioma Mpm Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Malignant Pleural Mesothelioma Mpm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 · 17 location(s) · Nurix Therapeutics, Inc. · NCT05107674
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Phase 1 · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT03760575
Multidimensional Omics Analysis in Malignant Pleural Mesothelioma
Phase N/A · 4 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT07561190
Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS
Phase N/A · 2 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06886672
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06037941
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.